Chronic Lymphocytic Leukemia Academy
The International Academy for Clinical Hematology (IACH) is proud to launch the IACH Chronic Lymphocytic Leukemia (CLL) Academy – a new educational initiative dedicated to fostering excellence in the understanding and management of CLL. As the therapeutic landscape of CLL continues to evolve with the advent of novel targeted agents, immunotherapies, and combination strategies, continuous education and knowledge exchange have become more essential than ever. The IACH CLL Academy aims to serve as a dynamic platform for expert-led dialogue, interactive case-based learning, and timely insights into the latest clinical evidence and treatment approaches. Through this initiative, IACH seeks to empower hematologists, oncologists, and healthcare professionals around the globe with the tools and knowledge necessary to advance patient care, while cultivating a strong, collaborative community committed to innovation and progress in hematology. The IACH Chronic Lymphocytic Leukemia Academy is made possible through the generous support of an unrestricted educational grant from BeOne Medicines (formely BeiGene).
For any questions please contact – [email protected]
The IACH Chronic Lymphocytic Leukemia Academy is supported by an unrestricted educational grant provided by BeOne Medicines.
